Michael A Rogawski

Sacramento, CA, United States of America

Michael A Rogawski

USPTO Granted Patents = 10 

 

 

Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 38(Granted Patents)


Location History:

  • Columbia, MD (US) (1993)
  • Sacramento, CA (US) (2013 - 2023)

Company Filing History:


Years Active: 1993-2025

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Michael A. Rogawski: Innovator in Pharmaceutical Compositions

Introduction

Michael A. Rogawski is a prominent inventor based in Sacramento, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of methods and compositions involving fospropofol. With a total of 10 patents to his name, Rogawski's work has had a substantial impact on medical treatments.

Latest Patents

Rogawski's latest patents focus on fospropofol methods and compositions. The present disclosure pertains to the use of fospropofol, pharmaceutically acceptable salts of fospropofol, or mixtures thereof. These pharmaceutical compositions are designed to treat various diseases or disorders, including migraines. His innovative approaches in this area highlight the potential of fospropofol in therapeutic applications.

Career Highlights

Throughout his career, Rogawski has worked with esteemed institutions such as the University of California and the Research Triangle Institute. His experience in these organizations has allowed him to advance his research and contribute to the scientific community effectively.

Collaborations

Some of his notable coworkers include Scott P. Runyon and Edgar Cook. Their collaborative efforts have further enriched the research environment in which Rogawski operates.

Conclusion

Michael A. Rogawski's contributions to pharmaceutical innovations, particularly in the realm of fospropofol, underscore his role as a leading inventor in the field. His work continues to influence medical treatments and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…